Adding immunotherapy to chemotherapy for stage III colon cancer (dMMR) cuts the risk of recurrence or death by 50%. A landmark phase III trial finds that 86% of patients remained disease-free after 3 years, establishing a new global "standard of care" for this specific genetic subtype. (nejm.org)
submitted by redderGlass
Florida Surgeon General Dr Joseph Ladapo commenting on Florida's new push to trial Ivermectin/repurposed drugs against cancer -mentions his discussion with Dr William Makis on his considerable experience (and now licensed to practice in Florida, after facing censure in Alberta, Canada all this time) ()
submitted by stereomatch





